Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent RE45174 Thiazolidin-4-one derivatives

Patent RE45174 was granted and assigned to Actelion on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Actelion

Current Assignee

Actelion

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

RE451740

Patent Inventor Names

Martin Bolli0

Oliver Nayler0

Boris Mathys0

Christoph Binkert0

Claus Mueller0

Michael Scherz0

Date of Patent

September 30, 2014

Patent Application Number

140287120

Date Filed

September 17, 2013

Patent Citations Received

‌

US Patent 11672783 Pharmaceutical combination comprising a selective S1P1 receptor agonist

‌

US Patent 11771683 Dosing regimen for a selective S1P

Patent Primary Examiner

‌

Laura L. Stockton

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent RE45174 Thiazolidin-4-one derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API